期刊文献+

脑梗死与颈动脉粥样硬化斑块及危险因素分析 被引量:3

Analysis of cerebral infarction with carotid atherosclerotic plague and risk factors
下载PDF
导出
摘要 目的探讨脑梗死与颈动脉粥样硬化(CAS)斑块及血脂、纤维蛋白原(FIB)、尿酸(UA)、C-反应蛋白(CRP)水平的关系。方法对108例经头颅CT或MRI确诊的急性脑梗死患者(脑梗死组)和86例健康体检者(对照组)进行颈动脉颅外段彩色多普勒超声检查,观察斑块情况。同时检测2组血脂、FIB、UA及CRP水平。结果脑梗死组CAS斑块检出率为77.78%高于对照组的19.77%,差异有统计学意义(P<0.01)。脑梗死组血清总胆固醇(TC)、低密度脂蛋白(LDL)、FIB、UA及CRP水平明显高于对照组(P<0.05);且有斑块亚组上述指标水平明显高于无斑块亚组(P<0.05)。结论 CAS斑块是脑梗死发生的重要因素,TC、LDL、FIB、UA及CRP水平增高是脑梗死及CAS斑块形成的危险因素。 Objective To discuss the relationship among cerebral infarction and carotid atherosclerosis(CAS) plague,levels of plasma lipid and fibrinogen(FIB)、serum uric acid(UA)、C-reactive protein(CRP).Methods 108 cases patients with cerebral infarction were detected by CT or MRI(cerebral infarction group),and 86 cases healthy(control group) were detected by color Doppler.To check the plague,the level of plasma lipid、FIB、UA and CRP in two groups.Results Rate of plague in cerebral infarction group(77.78%) was significantly higher than that in control group(19.77%)(P0.01);The level of total cholesterol(TC)、low density lipoprotein(LDL)、 FIB 、UA and CRP in cerebral infarction group were significant higher than those in control group(P0.05),and in cerebral infarction with plaque subgroup were significantly higher than those in cerebral infarction without plaque subgroup(P0.05).Conclusion CAS plague is a key factor of the occurrence of cerebral infarction.High levels of TC、LDL、FIB、UA and CRP are risk factors of cerebral infarction and CAS.
作者 董茂顺
出处 《临床合理用药杂志》 2011年第11期9-10,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 脑梗死 颈动脉粥样硬化斑块 危险因素 Cerebral infarction Carotid atherosclerotic plaque Risk factor
  • 相关文献

参考文献9

二级参考文献18

  • 1刘斌,石秋艳,李玉荣,张晋霞,宁树成,伊红丽,刘昊,陈桂华.脑梗死患者颈动脉粥样硬化斑块的调查及其相关因素分析[J].中国综合临床,2004,20(11):985-987. 被引量:21
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 3Wikxtrand J, Wiklund O. Frontiers in cardiovascular science: puantitative measurements of atherosclerotic in human[J]. Arterioscler Thromb, 1992,12(1): 114-119.
  • 4Yen Y, Doroshow J,Leong L, et al. Phase Ⅱ study of oxaliplatin in patients with unresectable, metastatic or recurrent hepatocellular cancer[J]. Proceedings of ASCO, 2004,22(14S) : 4169.
  • 5Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2007,27(2):266-274.
  • 6Sacco RL,Ben jamin EJ, Brogerick JP, et, al. American Heart Association Prevention Conference IV. Prevention and rehabilitation of stork risk factors[J]. Stroke, 1997, 28t 1 507-1 517.
  • 7Hegland O, Dickstein K, Larsen JP. Effect of simvastatin in preventing progression of carotid artery stenosis[J]. Am J cardiol, 2001,87(5) :643-645.
  • 8Chan Caarusone S, Smieja M, Molloy W, et al. Lack of association between vascular dementia and chlamydia pneumoniae infection :a case-control study[J]. BMC Neurol, 2004,4 (1) : 15.
  • 9Rosenson RS , Tangney CC. Antiatherothrombtic propertises of statins: implications for cardiovascular event reduction[J]. JAMA, 1998,279:1 643-1 650.
  • 10Handa N,Matsumoto M,Maeda H,et al. Ischemic stroke events and carotid atherosclerosis [J]. Stroke, 1995,26 ( 10 ): 1781-1786.

共引文献87

同被引文献21

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部